Connecticut Seal

General Assembly

File No. 180

    February Session, 2018

Substitute House Bill No. 5241

House of Representatives, April 4, 2018

The Committee on General Law reported through REP. D'AGOSTINO of the 91st Dist., Chairperson of the Committee on the part of the House, that the substitute bill ought to pass.

AN ACT CONCERNING PHARMACIST AND PRACTITIONER COMPLIANCE RATES AND THE ELECTRONIC PRESCRIPTION DRUG MONITORING PROGRAM.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

Section 1. (NEW) (Effective January 1, 2019) (a) The Commissioners of Public Health and Consumer Protection shall review the compliance rate of pharmacists and practitioners utilizing the electronic prescription drug monitoring program established pursuant to section 21a-254 of the general statutes.

(b) Not later than January 1, 2019, the Commissioners of Public Health and Consumer Protection shall jointly report, in accordance with section 11-4a of the general statutes, to the joint standing committees of the General Assembly having cognizance of matters relating to public health and consumer protection, regarding recommendations, if any, that they agree are necessary for pharmacists and practitioners to achieve one hundred per cent compliance with the electronic prescription drug monitoring program.

This act shall take effect as follows and shall amend the following sections:

Section 1

January 1, 2019

New section

GL

Joint Favorable Subst.

 

The following Fiscal Impact Statement and Bill Analysis are prepared for the benefit of the members of the General Assembly, solely for purposes of information, summarization and explanation and do not represent the intent of the General Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of informational sources, including the analyst's professional knowledge. Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.


OFA Fiscal Note

State Impact: None

Municipal Impact: None

Explanation

This bill requires the Commissioners of Public Health and Consumer Protection to review the compliance rate of pharmacists utilizing the prescription drug monitoring program and results in no cost to the state, as this task can be accomplished by existing staff with expertise in the area.

The Out Years

State Impact: None

Municipal Impact: None

OLR Bill Analysis

sHB 5241

AN ACT CONCERNING PHARMACIST AND PRACTITIONER COMPLIANCE RATES AND THE ELECTRONIC PRESCRIPTION DRUG MONITORING PROGRAM.

SUMMARY

This bill requires the public health and consumer protection commissioners to review pharmacists' and prescribing practitioners' compliance with the electronic Prescription Drug Monitoring Program's (PMP) requirements. By January 1, 2019, the commissioners must submit a joint report to the General Law and Public Health committees with their shared recommendations for increasing compliance rates. (The reporting deadline is the same as the bill's effective date.)

By law, (1) prescribers or their designees must consult the PMP database before issuing certain prescriptions for controlled substances and (2) pharmacists and dispensing practitioners must submit data to the PMP database promptly after dispensing controlled substance prescriptions (CGS 21a-254(j)).

EFFECTIVE DATE: January 1, 2019

COMMITTEE ACTION

General Law Committee

Joint Favorable Substitute

Yea

17

Nay

0

(03/20/2018)

TOP